跳至主要内容
临床试验/JPRN-UMIN000003951
JPRN-UMIN000003951已完成未知

Effect of a DPP-4 inhibitor or an alpha-glucosidase inhibitor on endothelial function in patients with type 2 diabetes - Effect of a DPP-4 inhibitor on endothelial function (EDGE)

Cardiovascular Dysfunction Study group0 个研究点目标入组 50 人开始时间: 2010年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1, The patient under insulin treatment 2, The patient under alpha-GI or Gulinide treatment 3, Type 1 diabetes mellitus 4, Insufficiently controlled diabetes mellitus (HbA1c >= 9.0% ) 5, Insufficiently controlled hypertension (SBP>=160mmHg) 6, Severe ketosis, diabetic coma, or precoma within the past six months 7, Severe infectious disease, pre/ post operation or serious injury 8, Women who are pregnant, possibly pregnant, or are breastfeeding 9, Mild renal dysfunction (sCr>=1.5 mg/dl) 10, Hypersensitivity or allergy to sitagliptin and voglibose 11, Patients who are determined by the investigators to be unsuitable

研究者

发起方
Cardiovascular Dysfunction Study group

相似试验

Effect of a DPP-4 inhibitor or an alpha-glucosidase... | 临床试验